HCA Healthcare beats top-line and bottom-line estimates; updates FY2026 outlook
Seeking Alpha ·
HCA Healthcare press release ( HCA ): Q2 Non-GAAP EPS of $7.59 beats by $0.09 . Revenue of $20.23B (+8.7% Y/Y) beats by $490M . Adjusted EBITDA increased 4.6 percent to $4.027 billion Cash flows from operating activities totaled $2.335 billion, compared to $4.210 billion in the
AI 시장 분석
HCA Healthcare reported a Q2 Non-GAAP EPS of $7.59 and revenue of $20.23 billion, surpassing market expectations. Revenue increased by 8.7% year-over-year, while adjusted EBITDA rose 4.6% to $4.027 billion. This strong performance demonstrates robust demand in the healthcare and medical services sector, providing positive signals for investors.
상승 영향
- Healthcare — HCA Healthcare's record of $20.23 billion in revenue and $7.59 in EPS proves the strong fundamentals of the medical services sector.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 39% · Bearish (Short) 61%
304 participants
Related News
- Zevra plunges on EU snub for rare disease therapy
- Alphabet falls below 200-day average for first time in over a year after earnings
- NanoViricides announces $3.8M registered direct offering; shares down
- FangDD receives Nasdaq notification
- Charter Communications shares pressured by loss of internet/video customers
- 삼성전자·SK하이닉스, 美 주요 기술 기업과 대규모 협약 발표 예정
